Springworks Therapeutics Inc (SWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 311,075 | 327,652 | 343,825 | N/A | N/A |
| TOTAL | $313,642 | $331,361 | $344,514 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 885 | 795 | 820 | N/A | N/A |
| Investments And Advances | 876 | 976 | 999 | 0 | 0 |
| Other Non-Current Assets | 2,005 | 1,699 | 2,062 | 0 | 0 |
| TOTAL | $3,766 | $3,470 | $3,881 | $N/A | $N/A |
| Total Assets | $317,408 | $334,831 | $348,395 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,617 | 2,654 | 2,157 | 0 | 0 |
| Accrued Expenses | 6,595 | 8,953 | 7,682 | N/A | N/A |
| Other current liabilities | 370 | 363 | 356 | N/A | N/A |
| TOTAL | $8,582 | $11,970 | $10,195 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 692 | 789 | 881 | 0 | 0 |
| TOTAL | $692 | $789 | $881 | $N/A | $N/A |
| Total Liabilities | $9,274 | $12,759 | $11,076 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,010 | 43,001 | 43,006 | N/A | N/A |
| Common Shares | 4 | 4 | 4 | N/A | N/A |
| Retained earnings | -88,323 | -73,029 | -56,812 | N/A | N/A |
| TOTAL | $308,134 | $322,072 | $337,319 | $N/A | $N/A |
| Total Liabilities And Equity | $317,408 | $334,831 | $348,395 | $0 | $0 |